相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies
Aziz Bousfiha et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2018)
Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders
Asbjorg Stray-Pedersen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
, Subcutaneous immunoglobulin treatment in CIDP and MMN. Efficacy, treatment satisfaction and costs
Lars H. Markvardsen et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
Construct and criterion validity of the pedsQL 4.0 instrument (Pediatric Quality of Life Inventory) in Colombia
Ana Carolina Amaya-Arias et al.
INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE (2017)
Clinical experiences in primary and secondary immunodeficiencies and immune-mediated conditions using Gammanorm
Ann Gardulf
IMMUNOTHERAPY (2016)
Subcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathies
Verena I. Leussink et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2016)
Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease
S. Jolles et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America
A. Condino-Neto et al.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA (2014)
Long-term efficacy, safety, and tolerability of Hizentra® for treatment of primary immunodeficiency disease
Stephen Jolles et al.
CLINICAL IMMUNOLOGY (2014)
Improving current immunoglobulin therapy for patients with primary immunodeficiency: quality of life and views on treatment
Teresa Espanol et al.
Patient Preference and Adherence (2014)
Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada
William C. Gerth et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2014)
Subcutaneous Immunoglobulin for Primary and Secondary Immunodeficiencies: an Evidence-Based Review
Jenny Lingman-Framme et al.
DRUGS (2013)
Comparative Study of Subcutaneous Versus Intravenous IgG Replacement Therapy in Pediatric Patients with Primary Immunodeficiency Diseases: A Multicenter Study in Argentina
Liliana Bezrodnik et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Economic benefits of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency
A. Martin et al.
TRANSFUSION MEDICINE (2013)
Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy
J. S. Orange et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
Incidence of Infection is Inversely Related to Steady-State (Trough) Serum IgG Level in Studies of Subcutaneous IgG in PIDD
Melvin Berger
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Immunoglobulin Dosage and Switch from Intravenous to Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Hypogammaglobulinemia: Decreasing Dosage Does Not Alter Serum IgG Levels
Sylvain Thepot et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Improved Quality of Life, Immunoglobulin G Levels, and Infection Rates in Patients with Primary Immunodeficiency Diseases during Self-Treatment with Subcutaneous Immunoglobulin G
Melvin Berger et al.
SOUTHERN MEDICAL JOURNAL (2010)
The Quality of Life of Children and Adolescents with X-Linked Agammaglobulinemia
Annarosa Soresina et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2009)
Prognostic factors for health-related quality of life in adults and children with primary antibody deficiencies receiving SCIG home therapy
A. Gardulf et al.
CLINICAL IMMUNOLOGY (2008)
Self-infusion Programmes for Immunoglobulin Replacement at Home: Feasibility, Safety and Efficacy
Malini V. Bhole et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2008)
Subcutaneous Administration of IgG
Melvin Berger
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2008)
Safety and efficacy of subcutaneous human immunoglobulin in children with primary immunodeficiency
Anders Fasth et al.
ACTA PAEDIATRICA (2007)
Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases
Hans D. Ochs et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2006)
Health-related quality of life and treatment satisfaction in North American patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at home
U Nicolay et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2006)
Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home
A Gardulf et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Express subcutaneous IgG infusions: Decreased time of delivery with maintained safety
S Hansen et al.
CLINICAL IMMUNOLOGY (2002)
The PedsQL (TM) in pediatric rheumatology - Reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory (TM) generic core scales and rheumatology module
JW Varni et al.
ARTHRITIS AND RHEUMATISM (2002)
PedsQL™ 4.0:: Reliability and validity of the pediatric quality of life Inventory™ Version 4.0 generic core scales in healthy and patient populations
JW Varni et al.
MEDICAL CARE (2001)
The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy
HM Chapel et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2000)
分享论文
